These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38450758)

  • 41. Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design.
    D'Ercole A; Nistri S; Pacini L; Carotenuto A; Santoro F; Papini AM; Bathgate RAD; Bani D; Rovero P
    Front Pharmacol; 2022; 13():942178. PubMed ID: 36034864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
    Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
    J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor-independent modulation of TGF-β-induced pro-fibrotic pathways by relaxin-2 in human primary tubular epithelial cells.
    Grampp S; Goppelt-Struebe M
    Cell Tissue Res; 2018 Dec; 374(3):619-627. PubMed ID: 30078103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.
    Lee JH; Koh SQ; Guadagna S; Francis PT; Esiri MM; Chen CP; Wong PT; Dawe GS; Lai MK
    Psychopharmacology (Berl); 2016 Feb; 233(4):591-8. PubMed ID: 26542729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action?
    Ma S; Shen PJ; Burazin TC; Tregear GW; Gundlach AL
    Neuroscience; 2006 Aug; 141(1):329-44. PubMed ID: 16725278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progesterone withdrawal, and not increased circulating relaxin, mediates the decrease in myometrial relaxin receptor (RXFP1) expression in late gestation in rats.
    Vodstrcil LA; Shynlova O; Westcott K; Laker R; Simpson E; Wlodek ME; Parry LJ
    Biol Reprod; 2010 Nov; 83(5):825-32. PubMed ID: 20686183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
    Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
    Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
    Wilson KJ; Xiao J; Chen CZ; Huang Z; Agoulnik IU; Ferrer M; Southall N; Hu X; Zheng W; Xu X; Wang A; Myhr C; Barnaeva E; George ER; Agoulnik AI; Marugan JJ
    Eur J Med Chem; 2018 Aug; 156():79-92. PubMed ID: 30006176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relaxin receptor RXFP1 signals through a mechanism of autoinhibition.
    Erlandson SC; Rawson S; Osei-Owusu J; Brock KP; Liu X; Paulo JA; Mintseris J; Gygi SP; Marks DS; Cong X; Kruse AC
    Nat Chem Biol; 2023 Aug; 19(8):1013-1021. PubMed ID: 37081311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2.
    Mookerjee I; Hewitson TD; Halls ML; Summers RJ; Mathai ML; Bathgate RA; Tregear GW; Samuel CS
    FASEB J; 2009 Apr; 23(4):1219-29. PubMed ID: 19073841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
    Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
    Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
    Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
    Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
    Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex- and age-specific differences in relaxin family peptide receptor expression within the hippocampus and amygdala in rats.
    Meadows KL; Byrnes EM
    Neuroscience; 2015 Jan; 284():337-348. PubMed ID: 25313002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.
    Fallowfield JA; Hayden AL; Snowdon VK; Aucott RL; Stutchfield BM; Mole DJ; Pellicoro A; Gordon-Walker TT; Henke A; Schrader J; Trivedi PJ; Princivalle M; Forbes SJ; Collins JE; Iredale JP
    Hepatology; 2014 Apr; 59(4):1492-504. PubMed ID: 23873655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis.
    Hoare BL; Kocan M; Bruell S; Scott DJ; Bathgate RAD
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00513. PubMed ID: 31384473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of serelaxin on renal microcirculation in rats under control and high-angiotensin environments.
    Shao W; Rosales CB; Gonzalez C; Prieto MC; Navar LG
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F70-F80. PubMed ID: 28978531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.